These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12375694)

  • 21. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.
    Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
    Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC
    Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.
    Buzzetti R; Petrone A; Ribaudo MC; Alemanno I; Zavarella S; Mein CA; Maiani F; Tiberti C; Baroni MG; Vecci E; Arca M; Leonetti F; Di Mario U
    Eur J Hum Genet; 2004 Dec; 12(12):1050-4. PubMed ID: 15367918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
    Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
    Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients.
    Jacob S; Stumvoll M; Becker R; Koch M; Nielsen M; Löblein K; Maerker E; Volk A; Renn W; Balletshofer B; Machicao F; Rett K; Häring HU
    Horm Metab Res; 2000 Oct; 32(10):413-6. PubMed ID: 11069206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU
    Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
    Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N
    Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.
    Johansson LE; Danielsson P; Norgren S; Marcus C; Ridderstråle M
    Int J Pediatr Obes; 2009; 4(2):119-25. PubMed ID: 18645733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population.
    Meshkani R; Taghikhani M; Mosapour A; Larijani B; Khatami S; Khoshbin E; Ahmadvand D; Saeidi P; Maleki A; Yavari K; Nasoohi N; Adeli K
    Arch Med Res; 2007 Jul; 38(5):556-62. PubMed ID: 17560463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
    Hu C; Jia W; Fang Q; Zhang R; Wang C; Lu J; Xiang K
    Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: skaraborg hypertension and diabetes project.
    Ostgren CJ; Lindblad U; Melander O; Melander A; Groop L; Råstam L
    J Hypertens; 2003 Sep; 21(9):1657-62. PubMed ID: 12923397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
    Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARgamma gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men.
    Kahara T; Takamura T; Hayakawa T; Nagai Y; Yamaguchi H; Katsuki T; Katsuki K; Katsuki M; Kobayashi K
    Metabolism; 2003 Feb; 52(2):209-12. PubMed ID: 12601634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.
    Evans D; de Heer J; Hagemann C; Wendt D; Wolf A; Beisiegel U; Mann WA
    Exp Clin Endocrinol Diabetes; 2001; 109(3):151-4. PubMed ID: 11409297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
    Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
    Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension.
    Rodríguez-Esparragón FJ; Rodríguez-Pérez JC; Macías-Reyes A; Alamo-Santana F
    J Hypertens; 2003 Sep; 21(9):1649-55. PubMed ID: 12923396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
    Buzzetti R; Petrone A; Caiazzo AM; Alemanno I; Zavarella S; Capizzi M; Mein CA; Osborn JA; Vania A; di Mario U
    Pediatr Res; 2005 Jan; 57(1):138-40. PubMed ID: 15531738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.